SKI Market

Indian Indices

Nifty

24,008.00 -265.80
(-1.10%)

Sensex

79,454.47 -880.34
( -1.10%)

Bank Nifty

53,595.25 -770.40
( -1.42%)

Nifty IT

35,880.10 -122.35
( -0.34%)

Global Indices

Nasdaq

41,266.30 -123.15
(-0.30%)

Dow Jones

5,680.75 -4.19
(-0.07%)

Hang Seng

37,492.25 563.62
(1.53%)

Nikkei 225

8,554.80 23.19
(0.27%)

Forex

USD-INR

85.39 0.69
(0.81%)

EUR-INR

96.28 0.21
(0.22%)

GBP-INR

113.48 0.52
(0.46%)

JPY-INR

0.59 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

322.4611705

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

18.62

96496.42

EPS(TTM)

Face Value()

Div & Yield %

62.12

0.69

Back

Balgopal Commercial reports standalone net loss of Rs 0.27 crore in the December 2024 quarter

Feb 14,2025

Net loss of Balgopal Commercial reported to Rs 0.27 crore in the quarter ended December 2024 as against net profit of Rs 3.70 crore during the previous quarter ended December 2023. Sales declined 97.98% to Rs 0.18 crore in the quarter ended December 2024 as against Rs 8.92 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0.18	8.92	-98
OPM %	-150.00	13.79	-
PBDT	-0.10	3.97	PL
PBT	-0.10	3.97	PL
NP	-0.27	3.70	PL

24,008.00 -265.80 (-1.10%)

79,454.47 -880.34 ( -1.10%)

53,595.25 -770.40 ( -1.42%)

35,880.10 -122.35 ( -0.34%)

41,266.30 -123.15 (-0.30%)

5,680.75 -4.19 (-0.07%)

37,492.25 563.62 (1.53%)

8,554.80 23.19 (0.27%)

85.39 0.69 (0.81%)

96.28 0.21 (0.22%)

113.48 0.52 (0.46%)

0.59 0.00 (-0.21%)